JP2018534267A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018534267A5 JP2018534267A5 JP2018516747A JP2018516747A JP2018534267A5 JP 2018534267 A5 JP2018534267 A5 JP 2018534267A5 JP 2018516747 A JP2018516747 A JP 2018516747A JP 2018516747 A JP2018516747 A JP 2018516747A JP 2018534267 A5 JP2018534267 A5 JP 2018534267A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pyridinyl
- cyclopropyl
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 13
- 150000001875 compounds Chemical class 0.000 claims 10
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 9
- 150000003839 salts Chemical class 0.000 claims 8
- -1 2-pyridinyl Chemical group 0.000 claims 5
- KPCZJLGGXRGYIE-UHFFFAOYSA-N [C]1=CC=CN=C1 Chemical group [C]1=CC=CN=C1 KPCZJLGGXRGYIE-UHFFFAOYSA-N 0.000 claims 5
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 5
- 208000023275 Autoimmune disease Diseases 0.000 claims 4
- 208000003456 Juvenile Arthritis Diseases 0.000 claims 4
- 206010059176 Juvenile idiopathic arthritis Diseases 0.000 claims 4
- 230000000172 allergic effect Effects 0.000 claims 4
- 208000010668 atopic eczema Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 208000035475 disorder Diseases 0.000 claims 4
- 201000002215 juvenile rheumatoid arthritis Diseases 0.000 claims 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 4
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 206010002556 Ankylosing Spondylitis Diseases 0.000 claims 2
- 206010003267 Arthritis reactive Diseases 0.000 claims 2
- 206010009900 Colitis ulcerative Diseases 0.000 claims 2
- 208000011231 Crohn disease Diseases 0.000 claims 2
- 206010012434 Dermatitis allergic Diseases 0.000 claims 2
- 208000009329 Graft vs Host Disease Diseases 0.000 claims 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 2
- 208000005777 Lupus Nephritis Diseases 0.000 claims 2
- 201000004681 Psoriasis Diseases 0.000 claims 2
- 201000001263 Psoriatic Arthritis Diseases 0.000 claims 2
- 208000036824 Psoriatic arthropathy Diseases 0.000 claims 2
- 206010039085 Rhinitis allergic Diseases 0.000 claims 2
- 206010039710 Scleroderma Diseases 0.000 claims 2
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 2
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 2
- 206010046851 Uveitis Diseases 0.000 claims 2
- 201000010105 allergic rhinitis Diseases 0.000 claims 2
- 208000006673 asthma Diseases 0.000 claims 2
- 208000019069 chronic childhood arthritis Diseases 0.000 claims 2
- 208000024908 graft versus host disease Diseases 0.000 claims 2
- 201000006417 multiple sclerosis Diseases 0.000 claims 2
- 125000004307 pyrazin-2-yl group Chemical group [H]C1=C([H])N=C(*)C([H])=N1 0.000 claims 2
- 208000002574 reactive arthritis Diseases 0.000 claims 2
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 2
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 2
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000003386 piperidinyl group Chemical group 0.000 claims 1
- 125000003373 pyrazinyl group Chemical group 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562235610P | 2015-10-01 | 2015-10-01 | |
| US62/235,610 | 2015-10-01 | ||
| PCT/US2016/054040 WO2017058831A1 (en) | 2015-10-01 | 2016-09-28 | Pteridine derivatives as modulators of ror gamma |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018534267A JP2018534267A (ja) | 2018-11-22 |
| JP2018534267A5 true JP2018534267A5 (https=) | 2019-11-14 |
| JP6778259B2 JP6778259B2 (ja) | 2020-10-28 |
Family
ID=57113781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018516747A Active JP6778259B2 (ja) | 2015-10-01 | 2016-09-28 | Ｒｏｒガンマのモジュレーターとしてのプテリジン誘導体 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US10450314B2 (https=) |
| EP (1) | EP3356366B1 (https=) |
| JP (1) | JP6778259B2 (https=) |
| WO (1) | WO2017058831A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ723530A (en) * | 2014-04-14 | 2023-05-26 | Boehringer Ingelheim Int | Compounds as modulators of ror gamma |
| CN109071516B (zh) | 2015-12-15 | 2021-08-31 | 阿斯利康(瑞典)有限公司 | 新颖的化合物 |
| WO2018193297A1 (en) | 2017-04-21 | 2018-10-25 | Cadila Healthcare Limited | Novel compounds as ror-gamma modulators |
| WO2018229155A1 (en) | 2017-06-14 | 2018-12-20 | Astrazeneca Ab | 2,3-dihydroisoindole-1-carboxamides useful as ror-gamma modulators |
| JP2022504780A (ja) | 2018-10-18 | 2022-01-13 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 光学活性１－シクロプロピルアルキル－１－アミンのスケーラブルな合成 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1786817A1 (de) * | 2004-08-26 | 2007-05-23 | Boehringer Ingelheim International GmbH | Pteridinone als plk (polo like kinase) inhibitoren |
| CA2837227C (en) * | 2011-06-01 | 2022-05-10 | Janus Biotherapeutics, Inc. | Novel immune system modulators |
| WO2014179564A1 (en) * | 2013-05-01 | 2014-11-06 | Vitae Pharmaceuticals, Inc. | Thiazalopyrrolidine inhibitors of ror-gamma |
| EP3027616B1 (en) | 2013-07-30 | 2018-01-10 | Boehringer Ingelheim International GmbH | Azaindole compounds as modulators of rorc |
| AU2015210833B2 (en) * | 2014-02-03 | 2019-01-03 | Vitae Pharmaceuticals, Llc | Dihydropyrrolopyridine inhibitors of ROR-gamma |
| NZ723530A (en) | 2014-04-14 | 2023-05-26 | Boehringer Ingelheim Int | Compounds as modulators of ror gamma |
-
2016
- 2016-09-28 EP EP16778622.7A patent/EP3356366B1/en active Active
- 2016-09-28 US US15/763,690 patent/US10450314B2/en active Active
- 2016-09-28 WO PCT/US2016/054040 patent/WO2017058831A1/en not_active Ceased
- 2016-09-28 JP JP2018516747A patent/JP6778259B2/ja active Active